Pharming Group N.V.
PHAR
$11.72
-$0.63-5.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | 06/30/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 131.42% | -197.84% | 131.89% | 131.89% | 376.50% |
| Total Depreciation and Amortization | -8.41% | 34.72% | 4.65% | 4.65% | -33.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.71% | 26.10% | -47.61% | -13.43% | 1,484.43% |
| Change in Net Operating Assets | -4,176.40% | 164.96% | -197.96% | -461.66% | -196.45% |
| Cash from Operations | -594.77% | -81.77% | 4,961.64% | 4,961.64% | -4.22% |
| Capital Expenditure | 65.13% | 11.52% | 54.61% | 54.61% | 64.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -37,833.04% | -74.67% | -74.67% | -304.83% |
| Cash from Investing | 99.90% | -188,255.56% | 74.96% | 74.96% | -325.06% |
| Total Debt Issued | -- | -- | -- | -- | 100.00% |
| Total Debt Repaid | 92.92% | -848.46% | -49.09% | -49.09% | -54.54% |
| Issuance of Common Stock | -68.54% | -26.12% | 334.02% | 334.02% | 9,004.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,097.60% | 95.60% | 56.17% | 56.17% | -1,212.26% |
| Cash from Financing | 73.48% | -988.44% | 58.97% | 58.97% | -53.80% |
| Foreign Exchange rate Adjustments | 132.63% | -172.47% | 211.41% | 211.41% | -454.82% |
| Miscellaneous Cash Flow Adjustments | 11,779,800.00% | -- | -- | -- | -- |
| Net Change in Cash | 213.96% | -818.41% | 521.44% | 521.44% | -142.29% |